Growing multi-omics Pleno Inc. is an early-stage biotechnology startup in San Diego developing a multi-omic instrument platform (RAPTOR) aimed at clinical testing and biomedical research, signaling a potential need for collaboration, lab integration, and early adopter partnerships in high-value diagnostics.

Strategic leadership Recent leadership change with a new CEO, Dr. Vik Vaz, and ongoing board/strategic hires suggest a company accelerating growth and planning aggressive commercialization, offering SDRs opportunities to engage around strategic partnerships, funding milestones, and channel collaborations.

Funding momentum Series B funding of 25M completed in December 2024 plus an overall 80M in funding indicate strong investor backing and expansion plans, creating openings for enterprise partnerships, early access programs, and pilot collaborations to validate the platform.

Platform focus Emphasis on Hypercoding and RAPTOR multi-omic instrument platform positions Pleno to target labs and CROs seeking cutting-edge detection capabilities, enabling upsell to hardware-software ecosystems, integration services, and long-term support contracts.

Talent and growth Active team expansion and involvement of seasoned executives and researchers imply a need for scalable collaboration tooling, professional services, and training partnerships to support rapid onboarding, system deployment, and customer success at scale.